← Every company
Takeda Pharmaceutical Co Ltd Planned Sales
Before an insider at Takeda Pharmaceutical Co Ltd can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
TAK insider trades →Notices on file
2
Insiders
2
Shares noticed
102.2K
permission to sell, not sales
Estimated value
$2.1M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Giles Richard PlatfordPresident, International Business Unit2026-11-0155.6K sh0.03% | $1.1M |
| Bitetti TeresaPresident, Global Oncology Business Unit2026-11-0146.6K sh0.02% | $940.1K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on TAK
Company overviewEverything on TAK in one place, with the price.SEC filingsWhat TAK's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat TAK's own officers and directors buy and sell.Who owns itEvery manager reporting a position in TAK.Funds holding itWhich funds and ETFs hold TAK, and how big a bet.LobbyingWhat TAK spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on TAK's account, and who they worked for.PatentsWhat TAK is filing at the patent office.